Researchers from the OHSU Cancer Institute Prostate Cancer Program recently presented results of their work to clinical researchers from around the world at the annual meeting of the American Society for Clinical Oncology, the world's leading professional organization representing physicians who treat people with cancer.
The Prostate Cancer Program is one of four growing programs of the OHSU Cancer Institute, which has a membership of some 140 researchers and physicians who are specialists in fields ranging from specific types of cancer - such as leukemia, prostate cancer and pediatric cancers - to epidemiology and bioinformatics.
More information on recent advances made by Prostate Cancer Program researchers is available via links below.
New Research from Jackilen Shannon PhD :
New Study Links Common Cholesterol-Lowering Drugs To Reduced Prostate Cancer Risk
New Research from Tomasz Beer MD :
New Patient Tools Needed To Reliably Report Side Effects In Chemotherapy Clinical Trials
New Study Shows Estrogen Patches Lower Cholesterol In Men With Prostate Cancer
Estrogen Boosts Memory In Men With Prostate Cancer
New Research from Mark Garzotto MD :
Increasingly Used Prostate Cancer Treatment Less Effective For Younger Men With Higher Grade Tumors
Negative Prostate Biopsy Doesn't Always Mean Cancer-Free
|
Tomasz M. Beer MD
Director of Prostate Cancer Research for the OHSU Cancer Institute
Visit his faculty page
Jackilen Shannon PhD
Assistant
Professor
Dept. of Public Health
Visit her faculty page
Mark Garzotto MD
Assistant
Professor
of Surgery/Urology
Visit his faculty page
|
